Drug profile · INN
mitomycin
MITOMYCIN
mitomycin (MITOMYCIN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 4
Pipeline programs 16
News articles 0
Drug details — mitomycin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 4
- Programs
- 16
- Data quality
- 0.84
Quick answer
mitomycin (MITOMYCIN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN mitomycin
Brand MITOMYCIN
Mechanism DNA inhibitor
Target DNA
Route TOPICAL
Formulation INJECTABLE
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is mitomycin?
mitomycin (MITOMYCIN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for mitomycin?
MITOMYCIN is a marketed brand name for mitomycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mitomycin?
mitomycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.